Syntekabio
Daejeon
About Syntekabio
Syntekabio is a Korean biotech firm, developing personal genome map which is expected to enable personalized medical service. The company also provides a technology for collecting and integrating decrypted whole genome data.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $211.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2024)
- Ticker: kosdaq:226330.KQ
- Website: syntekabio.com
- Phone: 212-371-2544
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Information Technology, Medical
Social Profiles
Canonical: https://fsome.com/organization/syntekabio-29477 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.